GlassScriptPhysician profile
Julia Lubsky
NPI 1235405234
$3,800.04
in general payments reported to CMS, 2019-2025
32 companies · $1,743 in 2025
The $1,743 reported for 2025 was more than what 89% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $227 · 2021: $229 · 2022: $346 · 2023: $477 · 2024: $528 · 2025: $1,743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,551 · Travel and Lodging: $1,197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,551.39 |
| Travel and Lodging | $1,196.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,196.57 | 2025 | |
| Abbvie INC. | $253.86 | 2019-2023 | |
| Pfizer INC. | $217.39 | 2022-2025 | |
| Exeltis, USA INC. | $206.13 | 2020-2024 | Slynd |
| Sumitomo Pharma America, INC. | $189.39 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $170.71 | 2023-2025 | Veozah |
| Ethicon US, LLC | $157.78 | 2025 | Ethicon, Vistaseal, Stratafix |
| Bayer Healthcare Pharmaceuticals INC. | $155.43 | 2019-2025 | |
| Therapeuticsmd, INC. | $152.56 | 2019-2022 | |
| Amgen INC. | $119.50 | 2021-2025 | Evenity, Prolia, Prolia |
| Conmed Corporation | $112.91 | 2019 | |
| Aspira Women'S Health INC | $112.57 | 2021-2023 | Ova1 |
| Sage Therapeutics, LLC | $92.11 | 2021-2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $79.54 | 2024 | Gardasil, Gardasil 9 |
| Organon LLC | $76.63 | 2022-2025 | Nexplanon |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $75.28 | 2020-2025 | Intrarosa, Femring, Femlyv |
| Mayne Pharma Commercial LLC | $65.93 | 2024-2025 | |
| Exact Sciences Corporation | $53.27 | 2023 | Cologuard Collection Kit |
| Myovant Sciences INC. | $48.17 | 2022 | |
| Hologic Sales and Service, LLC | $37.89 | 2021-2025 | Aptima |
| Coopersurgical, INC. | $37.43 | 2024-2025 | Paragard T 380a |
| Evofem Biosciences, INC. | $28.77 | 2022-2024 | |
| Supernus Pharmaceuticals, INC. | $23.31 | 2025 | Qelbree |
| Shield Therapeutics INC | $21.50 | 2023 | Accrufer |
| Minerva Surgical, INC | $15.73 | 2025 | |
| Aesculap, INC. | $15.60 | 2019 | |
| Scynexis, INC. | $15.59 | 2022 | |
| Amag Pharmaceuticals, INC. | $15.33 | 2020 | |
| Avion Pharmaceuticals | $14.00 | 2022 | |
| Meditrina | $13.57 | 2025 | |
| Lupin INC. | $13.42 | 2019 | |
| Allergan, INC. | $12.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Lubsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.